173 related articles for article (PubMed ID: 20167994)
1. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
Corbett AH; Hosseinipour MC; Nyirenda J; Kanyama C; Rezk NL; Mkupani P; Sichali D; Tien H; Kashuba AD; Mwansambo C; Weigel R; Kazembe P
Antivir Ther; 2010; 15(1):83-90. PubMed ID: 20167994
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
Hosseinipour MC; Corbett AH; Kanyama C; Mshali I; Phakati S; Rezk NL; van der Horst C; Kashuba AD
AIDS; 2007 Jan; 21(1):59-64. PubMed ID: 17148968
[TBL] [Abstract][Full Text] [Related]
3. Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.
Poerksen G; Pollock L; Moons P; Chesshyre E; Burger D; Khoo S; Molyneux E
Antivir Ther; 2010; 15(3):343-50. PubMed ID: 20516554
[TBL] [Abstract][Full Text] [Related]
4. Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.
Byakika-Tusiime J; Chinn LW; Oyugi JH; Obua C; Bangsberg DR; Kroetz DL
PLoS One; 2008; 3(12):e3981. PubMed ID: 19096711
[TBL] [Abstract][Full Text] [Related]
5. Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
Byakika-Kibwika P; Lamorde M; Kalemeera F; D'Avolio A; Mauro S; Di Perri G; Ryan M; Mayanja-Kizza H; Khoo S; Back D; Boffito M; Merry C
J Antimicrob Chemother; 2008 Nov; 62(5):1113-7. PubMed ID: 18641036
[TBL] [Abstract][Full Text] [Related]
6. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.
Vanprapar N; Cressey TR; Chokephaibulkit K; Muresan P; Plipat N; Sirisanthana V; Prasitsuebsai W; Hongsiriwan S; Chotpitayasunondh T; Eksaengsri A; Toye M; Smith ME; McIntosh K; Capparelli E; Yogev R;
Pediatr Infect Dis J; 2010 Oct; 29(10):940-4. PubMed ID: 20453709
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
Chokephaibulkit K; Cressey TR; Capparelli E; Sirisanthana V; Muresan P; Hongsiriwon S; Ngampiyaskul C; Limwongse C; Wittawatmongkol O; Aurpibul L; Kabat B; Toye M; Smith ME; Eksaengsri A; McIntosh K; Yogev R;
Antivir Ther; 2011; 16(8):1287-95. PubMed ID: 22155910
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
Fillekes Q; Mulenga V; Kabamba D; Kankasa C; Thomason MJ; Cook A; Ferrier A; Chintu C; Walker AS; Gibb DM; Burger DM
AIDS; 2012 Sep; 26(14):1795-800. PubMed ID: 22739394
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
Ellis JC; L'homme RF; Ewings FM; Mulenga V; Bell F; Chileshe R; Molyneux E; Abernethy J; van Oosterhout JJ; Chintu C; Walker AS; Gibb DM; Burger DM
Antivir Ther; 2007; 12(2):253-60. PubMed ID: 17503667
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations.
Mukherjee A; Singla M; Velpandian T; Sirohiwal A; Vajpayee M; Singh R; Kabra SK; Lodha R
Indian Pediatr; 2014 Mar; 51(3):191-7. PubMed ID: 24736906
[TBL] [Abstract][Full Text] [Related]
11. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
L'homme RF; Kabamba D; Ewings FM; Mulenga V; Kankasa C; Thomason MJ; Walker AS; Chintu C; Burger DM; Gibb DM
AIDS; 2008 Mar; 22(5):557-65. PubMed ID: 18316996
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
Chokephaibulkit K; Plipat N; Cressey TR; Frederix K; Phongsamart W; Capparelli E; Kolladarungkri T; Vanprapar N
AIDS; 2005 Sep; 19(14):1495-9. PubMed ID: 16135903
[TBL] [Abstract][Full Text] [Related]
13. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
Monif T; Rao Thudi N; Koundinya Tippabhotla S; Khuroo A; Marwah A; Kumar Shrivastav V; Tandon M; Raghuvanshi R; Biswal S
Clin Ther; 2007 Dec; 29(12):2677-84. PubMed ID: 18201583
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.
Pollock L; Else L; Poerksen G; Molyneux E; Moons P; Walker S; Fraser W; Back D; Khoo S
J Antimicrob Chemother; 2009 Dec; 64(6):1251-9. PubMed ID: 19812065
[TBL] [Abstract][Full Text] [Related]
15. Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
Burger D; Ewings F; Kabamba D; L'homme R; Mulenga V; Kankasa C; Thomason M; Gibb DM; Chintu C; Walker AS
Ther Drug Monit; 2010 Jun; 32(3):369-72. PubMed ID: 20386361
[TBL] [Abstract][Full Text] [Related]
16. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
Siegfried NL; Van Deventer PJ; Mahomed FA; Rutherford GW
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004535. PubMed ID: 16625606
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults.
L'homme RF; Dijkema T; Warris A; van der Ven AJ; Gibb DM; Burger DM
J Antimicrob Chemother; 2007 Jan; 59(1):92-6. PubMed ID: 17071953
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.
Taylor S; van Heeswijk RP; Hoetelmans RM; Workman J; Drake SM; White DJ; Pillay D
AIDS; 2000 Sep; 14(13):1979-84. PubMed ID: 10997403
[TBL] [Abstract][Full Text] [Related]
19. The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.
Barlow-Mosha LN; Bagenda DS; Mudiope PK; Mubiru MC; Butler LM; Fowler MG; Musoke PM
Afr Health Sci; 2012 Sep; 12(3):249-58. PubMed ID: 23382737
[TBL] [Abstract][Full Text] [Related]
20. Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.
Yogev R; Lee S; Wiznia A; Nachman S; Stanley K; Pelton S; Mofenson L; Fiscus S; Jimenez E; Rathore MH; Smith ME; Song LY; McIntosh K;
Pediatr Infect Dis J; 2002 Feb; 21(2):119-25. PubMed ID: 11840078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
